Research Recovery Program is Designed to Sustain Laboratories and Preserve High-Quality, High-Potential NIH or DoD ...

An effort to make NIH-funded research immediately accessible to the public has led to disruption and financial strain for ...

Amid NIH funding delays, clawbacks and uncertainty, a scientist at Harvard who studies breast cancer has lost one third of her lab employees and wonders if she can continue her research experiments.

Leptomeningeal metastases (LM) are a rare but severe complication of advanced cancer, affecting the fluid-lined structures of ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system ...

The Trump administration has slashed funding for medical research, delaying some treatments and cures for health conditions ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Our recent FDA meeting was very constructive, building on multiple previous positive meetings with the FDA on the clinical development and manufacturing of Reyobiq for CNS cancers,” said Dr. Marc H.

Scientists are decoding the biology behind debilitating illnesses such as lupus, known for its variety of symptoms ...

We couldn’t do our work at Penn State and other universities without the help of a grant from the federal government through the National Institutes of Health.” ...

Good morning, and welcome to The Washington Post. I’m Gina Cooper, managing director of Washington Post Live. Thank you so much to everyone who’s here in the room joining us this morning and to ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for ...